Holen Sie sich die Stockscreener-App
0.73
5.45%
0.0377
Vorhandelsmarkt:
.74
0.01
+1.37%
Schlusskurs vom Vortag:
$0.6923
Offen:
$0.73
24-Stunden-Volumen:
7.72M
Relative Volume:
0.80
Marktkapitalisierung:
$83.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-27.11M
KGV:
-1.1231
EPS:
-0.65
Netto-Cashflow:
$-26.55M
1W Leistung:
+22.77%
1M Leistung:
+32.75%
6M Leistung:
-13.10%
1J Leistung:
-71.03%
1-Tages-Spanne:
$0.7079
$0.7517
1-Wochen-Bereich:
$0.5958
$0.7517
52-Wochen-Spanne:
$0.2522
$2.97
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
(408) 501-8881
Adresse
10080 N WOLFE ROAD, CUPERTINO
Vergleichen Sie RVPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.73 | 79.66M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
Reviva Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RVPH) - MarketBeat
Trend Reversal Possible in Dhampur Bio Organics Limited Charts IndicateMarket Capitalization Trends & Small Entry Capital Stocks - earlytimes.in
Published on: 2025-12-06 19:16:30 - BỘ NỘI VỤ
How supply chain issues affect Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Is RVPH Positioned For NDA Submission In Schizophrenia By 2026? - RTTNews
Reviva’s Schizophrenia Bet Pits Huge Upside Against Harsh Risks - Finimize
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock maintain growth trajectory2025 Trading Recap & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
Largest borrow rate increases among liquid names - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
EBIT per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm – NASDAQ:RVPHW - TradingView
RVPH: Brilaroxazine Poster Presentations - Yahoo Finance
Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm - TradingView
How currency fluctuations impact Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockLayoff News & Real-Time Volume Analysis Alerts - newser.com
Analysts Conflicted on These Consumer Goods Names: Clene (CLNN) and Target (TGT) - The Globe and Mail
Reviva Pharmaceuticals Holdings (RVPH) Price Target Increased by 34.17% to 5.86 - MSN
Is Reviva Pharmaceuticals Holdings Inc. forming a bottoming baseChart Signals & Stepwise Swing Trade Plans - newser.com
Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs after earnings2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Full technical analysis of Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockTrade Entry Report & Weekly Momentum Picks - newser.com
Free cash flow per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva - TradingView
Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainableMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
MSN Money - MSN
Best data tools to analyze Reviva Pharmaceuticals Holdings Inc. stock2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explainedLayoff News & Weekly Top Stock Performers List - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Reviva Pharmaceuticals Holdings options imply 21.1% move in share price post-earnings - MSN
What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantMarket Movement Recap & AI Driven Price Forecasts - newser.com
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options data2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Reviva Pharmaceuticals reports Q3 EPS (6c), consensus (10c) - MSN
Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity Warrant - newser.com
Risk adjusted return profile for Reviva Pharmaceuticals Holdings Inc. Equity Warrant analyzedGlobal Markets & Community Trade Idea Sharing Platform - newser.com
What analysts say about Reviva Pharmaceuticals Holdings Inc stockEarnings Beat Highlights & Interactive Charts for Smarter Trading - earlytimes.in
Reviva Cuts Losses And Draws Optimism On New Drug Hopes - Finimize
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):